| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 115 | 2022 | 1503 | 6.670 |
Why?
|
| Prenatal Exposure Delayed Effects | 32 | 2021 | 155 | 5.950 |
Why?
|
| Acidosis | 15 | 2021 | 49 | 5.720 |
Why?
|
| Fetal Growth Retardation | 22 | 2019 | 51 | 4.950 |
Why?
|
| Obesity | 20 | 2022 | 965 | 4.150 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 13 | 2020 | 23 | 4.050 |
Why?
|
| Fetal Development | 14 | 2019 | 29 | 3.920 |
Why?
|
| Fetus | 19 | 2021 | 103 | 3.740 |
Why?
|
| Malnutrition | 11 | 2016 | 45 | 3.190 |
Why?
|
| Heart Rate, Fetal | 10 | 2021 | 12 | 3.010 |
Why?
|
| Animals, Newborn | 25 | 2020 | 323 | 2.760 |
Why?
|
| Female | 125 | 2022 | 19873 | 2.730 |
Why?
|
| Appetite | 8 | 2020 | 19 | 2.670 |
Why?
|
| Hyperphagia | 6 | 2020 | 14 | 2.480 |
Why?
|
| Rats | 55 | 2019 | 3261 | 2.250 |
Why?
|
| Animals | 93 | 2022 | 14307 | 2.230 |
Why?
|
| Rats, Sprague-Dawley | 43 | 2019 | 1534 | 2.080 |
Why?
|
| Placenta | 11 | 2014 | 91 | 2.010 |
Why?
|
| Hypothalamus | 12 | 2020 | 122 | 2.000 |
Why?
|
| Fetal Hypoxia | 5 | 2015 | 5 | 1.840 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 11 | 2015 | 14 | 1.750 |
Why?
|
| Fetal Diseases | 5 | 2021 | 6 | 1.730 |
Why?
|
| Adipose Tissue | 6 | 2022 | 167 | 1.700 |
Why?
|
| Birth Weight | 11 | 2017 | 93 | 1.570 |
Why?
|
| Fetal Blood | 6 | 2018 | 47 | 1.550 |
Why?
|
| Aquaporins | 5 | 2010 | 15 | 1.450 |
Why?
|
| Sheep | 19 | 2015 | 70 | 1.440 |
Why?
|
| Delivery, Obstetric | 4 | 2022 | 38 | 1.380 |
Why?
|
| Amnion | 6 | 2011 | 17 | 1.370 |
Why?
|
| Diabetes, Gestational | 5 | 2014 | 46 | 1.350 |
Why?
|
| Humans | 64 | 2022 | 34853 | 1.290 |
Why?
|
| Fetal Nutrition Disorders | 4 | 2009 | 9 | 1.290 |
Why?
|
| Infant, Newborn | 14 | 2022 | 871 | 1.290 |
Why?
|
| Leptin | 6 | 2011 | 115 | 1.270 |
Why?
|
| Amniotic Fluid | 8 | 2011 | 15 | 1.230 |
Why?
|
| Insulin | 5 | 2016 | 224 | 1.190 |
Why?
|
| Inflammation Mediators | 5 | 2014 | 120 | 1.190 |
Why?
|
| Labor, Obstetric | 5 | 2015 | 15 | 1.190 |
Why?
|
| Pregnancy, Animal | 5 | 2008 | 16 | 1.180 |
Why?
|
| Neuropeptide Y | 6 | 2016 | 23 | 1.180 |
Why?
|
| Pregnancy Complications | 5 | 2011 | 132 | 1.120 |
Why?
|
| Hypoxia, Brain | 2 | 2018 | 7 | 1.090 |
Why?
|
| Cell Differentiation | 6 | 2020 | 562 | 1.090 |
Why?
|
| Cyclic AMP | 4 | 2008 | 125 | 1.080 |
Why?
|
| Cervix Uteri | 4 | 2016 | 43 | 1.070 |
Why?
|
| Neurons | 6 | 2020 | 1130 | 1.060 |
Why?
|
| Satiation | 4 | 2020 | 8 | 1.040 |
Why?
|
| Adipogenesis | 3 | 2013 | 12 | 1.040 |
Why?
|
| Deglutition | 4 | 2005 | 28 | 1.020 |
Why?
|
| Neurogenesis | 5 | 2020 | 55 | 1.010 |
Why?
|
| Lipoprotein Lipase | 2 | 2022 | 5 | 0.930 |
Why?
|
| Breast Feeding | 3 | 2021 | 105 | 0.920 |
Why?
|
| Birth Injuries | 2 | 2018 | 9 | 0.920 |
Why?
|
| Fetal Monitoring | 4 | 2012 | 5 | 0.920 |
Why?
|
| Meconium | 4 | 2007 | 10 | 0.910 |
Why?
|
| Hypertension | 8 | 2013 | 770 | 0.910 |
Why?
|
| Umbilical Cord | 6 | 2021 | 13 | 0.900 |
Why?
|
| Mammary Glands, Animal | 1 | 2022 | 25 | 0.900 |
Why?
|
| Pregnancy Outcome | 5 | 2011 | 90 | 0.890 |
Why?
|
| Labor Stage, Second | 1 | 2022 | 2 | 0.880 |
Why?
|
| Arginine Vasopressin | 4 | 2008 | 13 | 0.850 |
Why?
|
| Water Deprivation | 3 | 2007 | 5 | 0.850 |
Why?
|
| Premature Birth | 2 | 2016 | 71 | 0.850 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2017 | 33 | 0.840 |
Why?
|
| Hypernatremia | 4 | 2005 | 10 | 0.840 |
Why?
|
| Labor Presentation | 1 | 2021 | 2 | 0.830 |
Why?
|
| Head | 1 | 2021 | 30 | 0.810 |
Why?
|
| Fetal Weight | 3 | 2017 | 9 | 0.810 |
Why?
|
| Cell Proliferation | 5 | 2019 | 1149 | 0.810 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2015 | 342 | 0.800 |
Why?
|
| Body Weight | 12 | 2016 | 404 | 0.790 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 35 | 0.770 |
Why?
|
| Child Development | 1 | 2021 | 84 | 0.760 |
Why?
|
| Liver | 11 | 2021 | 447 | 0.740 |
Why?
|
| Cerebral Palsy | 2 | 2018 | 11 | 0.740 |
Why?
|
| Patient Readmission | 1 | 2021 | 74 | 0.740 |
Why?
|
| Developmental Biology | 1 | 2019 | 7 | 0.730 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 5 | 0.730 |
Why?
|
| RNA, Messenger | 14 | 2022 | 1152 | 0.730 |
Why?
|
| Lipopolysaccharides | 5 | 2012 | 200 | 0.730 |
Why?
|
| Lactation | 4 | 2022 | 38 | 0.720 |
Why?
|
| Publishing | 1 | 2019 | 25 | 0.710 |
Why?
|
| Male | 33 | 2022 | 18870 | 0.710 |
Why?
|
| Fetofetal Transfusion | 1 | 2019 | 1 | 0.700 |
Why?
|
| Prenatal Care | 3 | 2011 | 74 | 0.700 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 48 | 0.690 |
Why?
|
| Jurisprudence | 1 | 2018 | 3 | 0.690 |
Why?
|
| Epigenesis, Genetic | 5 | 2016 | 198 | 0.680 |
Why?
|
| Acetylcysteine | 2 | 2012 | 58 | 0.680 |
Why?
|
| Feeding Behavior | 5 | 2015 | 418 | 0.680 |
Why?
|
| Dietary Fats | 2 | 2011 | 115 | 0.680 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2014 | 605 | 0.670 |
Why?
|
| Cervical Length Measurement | 2 | 2016 | 2 | 0.670 |
Why?
|
| Disease Models, Animal | 15 | 2016 | 1300 | 0.660 |
Why?
|
| Agouti-Related Protein | 5 | 2020 | 11 | 0.660 |
Why?
|
| Sirtuin 1 | 3 | 2014 | 32 | 0.660 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2014 | 283 | 0.650 |
Why?
|
| Fetal Distress | 3 | 2007 | 4 | 0.640 |
Why?
|
| Anthropometry | 2 | 2008 | 91 | 0.620 |
Why?
|
| Cesarean Section | 5 | 2022 | 53 | 0.620 |
Why?
|
| Quality of Life | 1 | 2021 | 459 | 0.600 |
Why?
|
| Blood Pressure | 7 | 2013 | 613 | 0.600 |
Why?
|
| Kidney | 4 | 2008 | 322 | 0.600 |
Why?
|
| Epithelial Cells | 4 | 2022 | 366 | 0.590 |
Why?
|
| Inflammation | 3 | 2011 | 577 | 0.590 |
Why?
|
| Cannabis | 1 | 2018 | 75 | 0.580 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2020 | 79 | 0.580 |
Why?
|
| Cytokines | 5 | 2012 | 569 | 0.570 |
Why?
|
| Weaning | 3 | 2022 | 15 | 0.570 |
Why?
|
| DNA Methylation | 1 | 2019 | 301 | 0.560 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 70 | 0.550 |
Why?
|
| Ultrasonography | 1 | 2016 | 115 | 0.540 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2007 | 47 | 0.540 |
Why?
|
| Dystocia | 2 | 2006 | 5 | 0.530 |
Why?
|
| Pro-Opiomelanocortin | 5 | 2016 | 14 | 0.530 |
Why?
|
| Encephalitis | 2 | 2012 | 39 | 0.520 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 13 | 0.520 |
Why?
|
| Food Deprivation | 4 | 2015 | 30 | 0.520 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 8 | 0.520 |
Why?
|
| Placentation | 3 | 2014 | 7 | 0.520 |
Why?
|
| Sucrose | 2 | 2005 | 27 | 0.510 |
Why?
|
| Bradycardia | 1 | 2014 | 6 | 0.500 |
Why?
|
| Up-Regulation | 6 | 2016 | 490 | 0.500 |
Why?
|
| Caloric Restriction | 3 | 2009 | 29 | 0.490 |
Why?
|
| Plasma | 2 | 2005 | 29 | 0.490 |
Why?
|
| Hemorrhage | 2 | 2005 | 46 | 0.490 |
Why?
|
| Cholestasis | 1 | 2013 | 9 | 0.480 |
Why?
|
| Oligohydramnios | 2 | 2010 | 4 | 0.470 |
Why?
|
| Overnutrition | 3 | 2020 | 5 | 0.460 |
Why?
|
| Growth and Development | 1 | 2013 | 8 | 0.460 |
Why?
|
| Gastrointestinal Motility | 4 | 2007 | 18 | 0.460 |
Why?
|
| Adenylate Kinase | 2 | 2012 | 13 | 0.460 |
Why?
|
| Body Composition | 3 | 2014 | 146 | 0.460 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 33 | 0.450 |
Why?
|
| Gestational Age | 6 | 2016 | 190 | 0.440 |
Why?
|
| Fatty Acids | 3 | 2022 | 118 | 0.440 |
Why?
|
| Bethanechol | 3 | 2007 | 3 | 0.440 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2012 | 5 | 0.440 |
Why?
|
| Appetite Regulation | 1 | 2012 | 8 | 0.430 |
Why?
|
| Postpartum Period | 2 | 2021 | 59 | 0.430 |
Why?
|
| Sex Characteristics | 2 | 2015 | 213 | 0.430 |
Why?
|
| Lactic Acid | 1 | 2012 | 87 | 0.430 |
Why?
|
| Mice | 6 | 2022 | 5668 | 0.420 |
Why?
|
| Muscle Contraction | 3 | 2007 | 63 | 0.420 |
Why?
|
| Benzhydryl Compounds | 3 | 2018 | 42 | 0.410 |
Why?
|
| Cells, Cultured | 5 | 2022 | 1442 | 0.410 |
Why?
|
| Water-Electrolyte Balance | 3 | 2005 | 17 | 0.410 |
Why?
|
| Organ Size | 6 | 2010 | 148 | 0.410 |
Why?
|
| Ghrelin | 2 | 2008 | 12 | 0.400 |
Why?
|
| Obstetric Labor, Premature | 3 | 2010 | 12 | 0.400 |
Why?
|
| Phenols | 3 | 2018 | 76 | 0.400 |
Why?
|
| Basal Metabolism | 1 | 2011 | 6 | 0.400 |
Why?
|
| Tight Junctions | 1 | 2011 | 24 | 0.390 |
Why?
|
| Immunohistochemistry | 7 | 2012 | 859 | 0.390 |
Why?
|
| Time Factors | 6 | 2022 | 1681 | 0.390 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2021 | 49 | 0.390 |
Why?
|
| Milk, Human | 2 | 2022 | 29 | 0.390 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2010 | 6 | 0.380 |
Why?
|
| Uterus | 2 | 2007 | 54 | 0.380 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2010 | 10 | 0.380 |
Why?
|
| Apoptosis | 3 | 2014 | 1317 | 0.370 |
Why?
|
| Glyburide | 1 | 2009 | 8 | 0.370 |
Why?
|
| Adult | 16 | 2021 | 11034 | 0.370 |
Why?
|
| Muscarinic Agonists | 2 | 2007 | 10 | 0.370 |
Why?
|
| Anorexia | 2 | 2007 | 4 | 0.370 |
Why?
|
| Chronic Disease | 2 | 2015 | 469 | 0.360 |
Why?
|
| Triglycerides | 5 | 2022 | 129 | 0.360 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2009 | 16 | 0.360 |
Why?
|
| Brain | 4 | 2012 | 1268 | 0.360 |
Why?
|
| Down Syndrome | 1 | 2009 | 29 | 0.360 |
Why?
|
| Serotonin | 1 | 2010 | 114 | 0.360 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 207 | 0.350 |
Why?
|
| Adiposity | 3 | 2022 | 145 | 0.350 |
Why?
|
| Eating | 3 | 2015 | 152 | 0.350 |
Why?
|
| Cardiotocography | 1 | 2009 | 2 | 0.350 |
Why?
|
| Extraembryonic Membranes | 2 | 2005 | 6 | 0.340 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 968 | 0.340 |
Why?
|
| Fatty Liver | 4 | 2013 | 56 | 0.340 |
Why?
|
| Chorion | 2 | 2005 | 8 | 0.330 |
Why?
|
| Action Potentials | 1 | 2010 | 219 | 0.330 |
Why?
|
| Aquaporin 1 | 1 | 2008 | 8 | 0.330 |
Why?
|
| Trophoblasts | 1 | 2008 | 22 | 0.330 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2012 | 29 | 0.330 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 152 | 0.320 |
Why?
|
| Angiotensin II | 2 | 2005 | 92 | 0.320 |
Why?
|
| Colon | 2 | 2007 | 98 | 0.320 |
Why?
|
| Infant Nutrition Disorders | 1 | 2007 | 2 | 0.320 |
Why?
|
| Mitochondria | 1 | 2011 | 454 | 0.320 |
Why?
|
| Pregnancy in Diabetics | 1 | 2007 | 4 | 0.310 |
Why?
|
| Shoulder | 2 | 2006 | 9 | 0.310 |
Why?
|
| Cardiovascular System | 2 | 2005 | 30 | 0.310 |
Why?
|
| Appetite Depressants | 1 | 2007 | 8 | 0.310 |
Why?
|
| Organogenesis | 1 | 2007 | 16 | 0.310 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 14 | 0.310 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 555 | 0.310 |
Why?
|
| Antioxidants | 2 | 2012 | 386 | 0.300 |
Why?
|
| Aging | 2 | 2009 | 639 | 0.300 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 51 | 0.300 |
Why?
|
| Brain Chemistry | 2 | 2004 | 134 | 0.300 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2007 | 25 | 0.300 |
Why?
|
| Vascular Diseases | 1 | 2007 | 30 | 0.300 |
Why?
|
| Neck Injuries | 1 | 2006 | 10 | 0.290 |
Why?
|
| Embryonic and Fetal Development | 2 | 2003 | 37 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 70 | 0.290 |
Why?
|
| Sheep, Domestic | 5 | 2011 | 7 | 0.290 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2013 | 23 | 0.290 |
Why?
|
| Aquaporin 3 | 1 | 2006 | 3 | 0.290 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 59 | 0.290 |
Why?
|
| Fasting | 1 | 2006 | 50 | 0.280 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 127 | 0.280 |
Why?
|
| Electrocardiography | 1 | 2007 | 154 | 0.280 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 111 | 0.280 |
Why?
|
| Sex Factors | 6 | 2016 | 859 | 0.280 |
Why?
|
| Osmolar Concentration | 4 | 2010 | 55 | 0.270 |
Why?
|
| Cholinergic Agents | 1 | 2005 | 7 | 0.270 |
Why?
|
| Diet | 4 | 2022 | 747 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2016 | 1802 | 0.270 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2005 | 2 | 0.260 |
Why?
|
| Starvation | 1 | 2005 | 10 | 0.260 |
Why?
|
| Heart | 2 | 2011 | 178 | 0.260 |
Why?
|
| Risk Factors | 7 | 2021 | 3414 | 0.260 |
Why?
|
| Blotting, Western | 4 | 2012 | 834 | 0.260 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 109 | 0.260 |
Why?
|
| STAT3 Transcription Factor | 3 | 2011 | 80 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 131 | 0.260 |
Why?
|
| Prenatal Diagnosis | 3 | 2009 | 10 | 0.260 |
Why?
|
| Food Preferences | 2 | 2015 | 66 | 0.250 |
Why?
|
| Infant | 2 | 2020 | 1014 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 338 | 0.240 |
Why?
|
| Dehydration | 4 | 2005 | 21 | 0.240 |
Why?
|
| PPAR gamma | 4 | 2011 | 49 | 0.240 |
Why?
|
| Ileum | 1 | 2003 | 15 | 0.240 |
Why?
|
| Receptors, Muscarinic | 1 | 2003 | 16 | 0.240 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 23 | 0.240 |
Why?
|
| Disasters | 1 | 2005 | 64 | 0.240 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2003 | 9 | 0.240 |
Why?
|
| Ganglionic Stimulants | 1 | 2003 | 2 | 0.240 |
Why?
|
| Mothers | 2 | 2018 | 164 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 128 | 0.240 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2003 | 6 | 0.230 |
Why?
|
| Bucladesine | 1 | 2003 | 7 | 0.230 |
Why?
|
| Hyponatremia | 1 | 2003 | 6 | 0.230 |
Why?
|
| Obstetrics | 2 | 2018 | 38 | 0.230 |
Why?
|
| Primary Prevention | 1 | 2003 | 57 | 0.230 |
Why?
|
| Palmitates | 1 | 2022 | 13 | 0.230 |
Why?
|
| Ion Channels | 1 | 2003 | 69 | 0.230 |
Why?
|
| Milk Proteins | 1 | 2022 | 28 | 0.220 |
Why?
|
| Retrospective Studies | 3 | 2022 | 1961 | 0.220 |
Why?
|
| Corticosterone | 2 | 2014 | 73 | 0.220 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2015 | 72 | 0.220 |
Why?
|
| Magnesium Sulfate | 1 | 2002 | 5 | 0.220 |
Why?
|
| Tocolytic Agents | 1 | 2002 | 3 | 0.220 |
Why?
|
| Pituitary Gland | 1 | 2002 | 59 | 0.220 |
Why?
|
| Testosterone | 1 | 2003 | 181 | 0.220 |
Why?
|
| Drinking | 3 | 2010 | 37 | 0.220 |
Why?
|
| Prolapse | 1 | 2021 | 2 | 0.210 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2002 | 42 | 0.210 |
Why?
|
| Magnesium | 1 | 2002 | 95 | 0.210 |
Why?
|
| Membrane Proteins | 1 | 2005 | 486 | 0.200 |
Why?
|
| Pre-Eclampsia | 1 | 2002 | 57 | 0.200 |
Why?
|
| New York | 1 | 2021 | 69 | 0.200 |
Why?
|
| Hospitals, Private | 1 | 2021 | 6 | 0.200 |
Why?
|
| Electromyography | 3 | 2005 | 49 | 0.200 |
Why?
|
| Reference Values | 3 | 2007 | 204 | 0.190 |
Why?
|
| Cholesterol | 3 | 2013 | 194 | 0.190 |
Why?
|
| Receptors, Notch | 2 | 2011 | 32 | 0.190 |
Why?
|
| Risk Assessment | 2 | 2016 | 727 | 0.190 |
Why?
|
| Nicotine | 1 | 2003 | 238 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 3 | 2005 | 137 | 0.190 |
Why?
|
| Prospective Studies | 2 | 2016 | 1353 | 0.180 |
Why?
|
| Homeostasis | 3 | 2006 | 172 | 0.180 |
Why?
|
| Family | 1 | 2021 | 162 | 0.180 |
Why?
|
| Term Birth | 3 | 2014 | 9 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 881 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2019 | 74 | 0.180 |
Why?
|
| Receptors, Leptin | 2 | 2011 | 13 | 0.180 |
Why?
|
| Sodium | 3 | 2004 | 101 | 0.180 |
Why?
|
| Twins, Monozygotic | 1 | 2019 | 8 | 0.180 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 3 | 0.170 |
Why?
|
| Liability, Legal | 1 | 2018 | 4 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 18 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2011 | 80 | 0.160 |
Why?
|
| Nucleus Accumbens | 2 | 2015 | 80 | 0.160 |
Why?
|
| Arterioles | 2 | 2007 | 18 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2021 | 1318 | 0.150 |
Why?
|
| Pyridines | 2 | 2010 | 113 | 0.150 |
Why?
|
| Gene Expression | 3 | 2007 | 639 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 12 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2561 | 0.150 |
Why?
|
| Maternal Exposure | 1 | 2016 | 30 | 0.150 |
Why?
|
| Pancreas | 2 | 2007 | 32 | 0.140 |
Why?
|
| Litter Size | 2 | 2007 | 12 | 0.140 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 39 | 0.140 |
Why?
|
| Prognosis | 1 | 2019 | 707 | 0.140 |
Why?
|
| Smoking | 1 | 2003 | 903 | 0.140 |
Why?
|
| Kidney Diseases | 2 | 2011 | 159 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2009 | 333 | 0.140 |
Why?
|
| Aorta | 2 | 2007 | 161 | 0.140 |
Why?
|
| alpha-MSH | 1 | 2016 | 4 | 0.140 |
Why?
|
| Synaptic Potentials | 1 | 2016 | 7 | 0.140 |
Why?
|
| Phenotype | 3 | 2011 | 650 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 123 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 386 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 136 | 0.140 |
Why?
|
| Incidence | 1 | 2018 | 882 | 0.140 |
Why?
|
| Child | 2 | 2021 | 2875 | 0.140 |
Why?
|
| Blood Gas Analysis | 2 | 2005 | 5 | 0.130 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2015 | 18 | 0.130 |
Why?
|
| Probability | 2 | 2007 | 75 | 0.130 |
Why?
|
| Models, Animal | 1 | 2015 | 131 | 0.130 |
Why?
|
| Syndrome | 2 | 2005 | 72 | 0.130 |
Why?
|
| Energy Intake | 1 | 2016 | 160 | 0.130 |
Why?
|
| Menopause, Premature | 1 | 2014 | 5 | 0.130 |
Why?
|
| Stimulation, Chemical | 2 | 2005 | 19 | 0.130 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2014 | 17 | 0.130 |
Why?
|
| Lung | 2 | 2009 | 413 | 0.130 |
Why?
|
| Reward | 1 | 2015 | 73 | 0.130 |
Why?
|
| Fetal Death | 2 | 2005 | 15 | 0.130 |
Why?
|
| Twins | 2 | 2005 | 16 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 257 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 49 | 0.130 |
Why?
|
| Digestive System | 2 | 2005 | 19 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2007 | 137 | 0.120 |
Why?
|
| Food | 1 | 2015 | 95 | 0.120 |
Why?
|
| Ovary | 1 | 2014 | 101 | 0.120 |
Why?
|
| Cholic Acid | 1 | 2013 | 2 | 0.120 |
Why?
|
| Pancreatic Diseases | 1 | 2013 | 5 | 0.120 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2013 | 17 | 0.120 |
Why?
|
| Lipogenesis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Hematocrit | 2 | 2003 | 18 | 0.120 |
Why?
|
| Adolescent | 3 | 2016 | 5035 | 0.120 |
Why?
|
| Attention | 1 | 2015 | 147 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 31 | 0.120 |
Why?
|
| Stem Cells | 1 | 2014 | 132 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2015 | 133 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2013 | 33 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2013 | 32 | 0.110 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 48 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 146 | 0.110 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2013 | 35 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2013 | 56 | 0.110 |
Why?
|
| Algorithms | 2 | 2008 | 435 | 0.110 |
Why?
|
| Lipids | 1 | 2014 | 222 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2012 | 22 | 0.110 |
Why?
|
| Cytoprotection | 1 | 2012 | 32 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 13 | 0.110 |
Why?
|
| Fetal Organ Maturity | 2 | 2009 | 3 | 0.110 |
Why?
|
| Cell Line | 2 | 2008 | 1289 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 109 | 0.110 |
Why?
|
| Prosencephalon | 1 | 2011 | 25 | 0.100 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2011 | 9 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2013 | 166 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2012 | 63 | 0.100 |
Why?
|
| Fetal Movement | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2011 | 45 | 0.100 |
Why?
|
| Cytosol | 1 | 2011 | 85 | 0.100 |
Why?
|
| C-Reactive Protein | 2 | 2009 | 147 | 0.100 |
Why?
|
| Animal Feed | 1 | 2011 | 42 | 0.100 |
Why?
|
| Maternal Welfare | 1 | 2011 | 7 | 0.100 |
Why?
|
| Lactates | 1 | 2011 | 8 | 0.100 |
Why?
|
| Caspases | 1 | 2011 | 132 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2011 | 123 | 0.100 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 92 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 33 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 90 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 139 | 0.100 |
Why?
|
| Electrolytes | 1 | 2010 | 25 | 0.100 |
Why?
|
| Perception | 1 | 2012 | 183 | 0.100 |
Why?
|
| Nephrons | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cell Movement | 2 | 2011 | 545 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 121 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 642 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 80 | 0.100 |
Why?
|
| Fenfluramine | 1 | 2010 | 2 | 0.100 |
Why?
|
| Ritanserin | 1 | 2010 | 3 | 0.100 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2013 | 6 | 0.090 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 22 | 0.090 |
Why?
|
| Physicians | 1 | 2012 | 148 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 66 | 0.090 |
Why?
|
| Young Adult | 3 | 2016 | 4012 | 0.090 |
Why?
|
| Program Development | 1 | 2011 | 225 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 465 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2011 | 159 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2010 | 137 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2011 | 316 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 26 | 0.090 |
Why?
|
| Piperazines | 1 | 2010 | 109 | 0.090 |
Why?
|
| Darkness | 1 | 2009 | 27 | 0.090 |
Why?
|
| Photoperiod | 1 | 2009 | 26 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 274 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 2009 | 31 | 0.090 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2009 | 1 | 0.090 |
Why?
|
| Histones | 1 | 2010 | 177 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2009 | 140 | 0.090 |
Why?
|
| Physical Examination | 1 | 2009 | 40 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 13 | 0.080 |
Why?
|
| Thionucleotides | 1 | 2008 | 8 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 424 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 99 | 0.080 |
Why?
|
| California | 1 | 2009 | 436 | 0.080 |
Why?
|
| Observer Variation | 1 | 2007 | 57 | 0.080 |
Why?
|
| Polyhydramnios | 1 | 2007 | 2 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 89 | 0.080 |
Why?
|
| Splanchnic Circulation | 1 | 2007 | 4 | 0.080 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2007 | 2 | 0.080 |
Why?
|
| Pirenzepine | 1 | 2007 | 1 | 0.080 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 13 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2007 | 17 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 31 | 0.080 |
Why?
|
| Mesenteric Arteries | 1 | 2007 | 18 | 0.080 |
Why?
|
| Defecation | 1 | 2007 | 5 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 32 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2007 | 32 | 0.080 |
Why?
|
| Calcium | 1 | 2010 | 445 | 0.080 |
Why?
|
| United States | 2 | 2021 | 3894 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 63 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 445 | 0.070 |
Why?
|
| Obstetrical Forceps | 1 | 2006 | 3 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2007 | 42 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 38 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2007 | 124 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 135 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2006 | 65 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2007 | 53 | 0.070 |
Why?
|
| Peptide Hormones | 1 | 2006 | 19 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 157 | 0.070 |
Why?
|
| Kidney Glomerulus | 1 | 2007 | 80 | 0.070 |
Why?
|
| Allantois | 1 | 2005 | 1 | 0.070 |
Why?
|
| Administration, Sublingual | 1 | 2005 | 2 | 0.070 |
Why?
|
| Mass Screening | 1 | 2009 | 427 | 0.070 |
Why?
|
| Dizocilpine Maleate | 1 | 2005 | 45 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2006 | 69 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2005 | 24 | 0.070 |
Why?
|
| Mechanics | 1 | 2005 | 3 | 0.070 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 29 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 92 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 229 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2005 | 43 | 0.070 |
Why?
|
| Blood Volume | 1 | 2005 | 5 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2007 | 177 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2005 | 175 | 0.070 |
Why?
|
| Stomach | 1 | 2005 | 43 | 0.070 |
Why?
|
| Esophagus | 1 | 2005 | 41 | 0.070 |
Why?
|
| Endocrine Glands | 1 | 2004 | 3 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 53 | 0.070 |
Why?
|
| Parturition | 1 | 2005 | 22 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2005 | 130 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2004 | 11 | 0.070 |
Why?
|
| Hypotonic Solutions | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cues | 2 | 2015 | 54 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2004 | 60 | 0.060 |
Why?
|
| Prevalence | 1 | 2009 | 1425 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 310 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 125 | 0.060 |
Why?
|
| Losartan | 1 | 2004 | 31 | 0.060 |
Why?
|
| Growth | 1 | 2004 | 12 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2004 | 139 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2004 | 52 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 106 | 0.060 |
Why?
|
| Weight Gain | 1 | 2005 | 128 | 0.060 |
Why?
|
| Imidazoles | 1 | 2004 | 124 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2011 | 420 | 0.060 |
Why?
|
| Hypertonic Solutions | 1 | 2003 | 1 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 984 | 0.060 |
Why?
|
| Heart Rate | 1 | 2005 | 248 | 0.060 |
Why?
|
| Atropine | 1 | 2003 | 12 | 0.060 |
Why?
|
| Osmotic Pressure | 1 | 2003 | 20 | 0.060 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 12 | 0.060 |
Why?
|
| Blood | 1 | 2003 | 32 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 430 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 60 | 0.060 |
Why?
|
| Labor Stage, Third | 1 | 2003 | 1 | 0.060 |
Why?
|
| Differential Threshold | 1 | 2003 | 5 | 0.060 |
Why?
|
| Version, Fetal | 1 | 2003 | 3 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2007 | 775 | 0.060 |
Why?
|
| Chlorides | 1 | 2003 | 52 | 0.060 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2015 | 5 | 0.060 |
Why?
|
| Maternal Age | 1 | 2003 | 27 | 0.060 |
Why?
|
| Diuresis | 1 | 2003 | 7 | 0.060 |
Why?
|
| Solitary Nucleus | 1 | 2003 | 5 | 0.060 |
Why?
|
| Parity | 1 | 2003 | 46 | 0.060 |
Why?
|
| Progesterone | 1 | 2003 | 117 | 0.060 |
Why?
|
| Arteries | 1 | 2003 | 67 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 145 | 0.060 |
Why?
|
| Acute Disease | 1 | 2003 | 141 | 0.060 |
Why?
|
| Asphyxia Neonatorum | 1 | 2002 | 5 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1124 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 103 | 0.060 |
Why?
|
| Half-Life | 1 | 2002 | 52 | 0.050 |
Why?
|
| Ions | 1 | 2002 | 61 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 592 | 0.050 |
Why?
|
| Water | 1 | 2003 | 283 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 964 | 0.050 |
Why?
|
| Wnt Proteins | 2 | 2011 | 20 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 628 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2016 | 8 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 2015 | 22 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 72 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 65 | 0.030 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 68 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 13 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2015 | 160 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 528 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 288 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 298 | 0.030 |
Why?
|
| Motor Activity | 1 | 2015 | 393 | 0.030 |
Why?
|
| Electron Microscope Tomography | 1 | 2011 | 4 | 0.030 |
Why?
|
| Amino Acid Transport System A | 1 | 2011 | 2 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2011 | 3 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 15 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 17 | 0.030 |
Why?
|
| Acetyl Coenzyme A | 1 | 2011 | 7 | 0.030 |
Why?
|
| Gases | 1 | 2011 | 24 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 31 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 152 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 491 | 0.020 |
Why?
|
| Adipocytes | 1 | 2011 | 54 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 97 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 108 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 71 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 65 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 160 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 600 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 122 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 193 | 0.020 |
Why?
|
| Exercise | 1 | 2015 | 524 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 8 | 0.020 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2009 | 1 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 233 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 59 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 71 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2009 | 4 | 0.020 |
Why?
|
| Mast Cells | 1 | 2009 | 77 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2009 | 50 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2009 | 26 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 287 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2008 | 2 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 6 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2008 | 5 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Lipase | 1 | 2008 | 16 | 0.020 |
Why?
|
| Ureter | 1 | 2008 | 7 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2011 | 226 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 22 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 41 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2008 | 42 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 152 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 183 | 0.020 |
Why?
|
| Hippocampus | 1 | 2009 | 546 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 653 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 901 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 20 | 0.020 |
Why?
|
| Fluorescein | 1 | 2005 | 15 | 0.020 |
Why?
|
| Rabbits | 1 | 2005 | 278 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 2003 | 7 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 2003 | 12 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2003 | 107 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2003 | 51 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 396 | 0.010 |
Why?
|